The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma
Alexandra M. Nanzer, Victoria Taylor, A Hearn, Joanne Kavanagh, Tanya Patrick, Linda Green, Louise Thomson, J Lam, Mariana Fernandes, Cris Roxas, G d’Ancona, Brian D. Kent, Jaideep Dhariwal, David J. Jackson
Abstract
<h3>Tweetable abstract</h3> <b>Frequent use of oral corticosteroids can lead to adverse consequences, including weight gain. Treatment with steroid-sparing anti-IL5/5R biologic therapies for severe asthma is associated with significant weight loss in obese patients.</b>https://bit.ly/3PyWRYj
Topics & Concepts
MedicineAsthmaWeight lossAdverse effectSteroid useObesityInternal medicinePediatricsAsthma and respiratory diseasesIL-33, ST2, and ILC PathwaysRespiratory and Cough-Related Research